NewAmsterdam Pharma Co N.V. ($NAMS)
Filing Information
| Accession Number | 0001193125-26-312387 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 22, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
315,000
Total Value
$4,376,755.90
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer | Ordinary Shares | โ | Jul 20, 2026 | Exercise/Conversion | 25,000 | $11.90 | $297,500.00 | 49,353 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Jul 20, 2026 | Exercise/Conversion | 80,000 | $11.17 | $893,600.00 | 129,353 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Jul 20, 2026 | Sale | 70,200 | $29.96 | $2,103,192.00 | 59,153 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Jul 20, 2026 | Sale | 31,885 | $31.05 | $990,029.25 | 27,268 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Jul 20, 2026 | Sale | 2,915 | $31.71 | $92,434.65 | 24,353 | Direct | โ | View Details | |
Chief Accounting Officer | Option (right to buy) | Derivative | Jul 20, 2026 | Exercise/Conversion | 25,000 | $0.00 | $0.00 | 10,000 | Direct | โ | View Details | |
Chief Accounting Officer | Option (right to buy) | Derivative | Jul 20, 2026 | Exercise/Conversion | 80,000 | $0.00 | $0.00 | 70,494 | Direct | โ | View Details |